WHITNEY COLOMBO: Open Payments
NPI 1811619836 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$831 in 39 payments from 13 companies in 2025. Trend: 2023 $997 · 2024 $656 · 2025 $831
Food & beverage: $831
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 9 | $218 |
| UROGEN PHARMA, INC. | 7 | $141 |
| Merck Sharp & Dohme LLC | 4 | $92 |
| Sumitomo Pharma America, Inc. | 4 | $82 |
| IMMUNITYBIO, INC. | 3 | $75 |
| Antares Pharma, Inc. | 3 | $47 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $38 |
| Novartis Pharmaceuticals Corporation | 2 | $30 |
| ACCORD HEALTHCARE, INC. | 1 | $27 |
| Endo USA, Inc. | 1 | $25 |
Products named: ERLEADA, ANKTIVA, LYNPARZA, GEMTESA, XYOSTED, Nubeqa, PLUVICTO, Camcevi.
Industry payments across AL — which companies pay providers there.
